Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact [email protected].
BOSTON, MASSACHUSETTS, May 20, 2020 – Atea Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of next-generation therapeutics for severe human viral infections, today announced a $215 million Series D financing. The financing was led by Bain Capital Life Sciences and also included new investors RA Capital Management, Perceptive Advisors, Rock Springs...
IRVINE, California-JenaValve Technology, Inc., developer and manufacturer of the JenaValve Pericardial Transcatheter Aortic Valve Replacement (TAVR) System for the treatment of aortic valve disease, announces that it has raised $50 million in an equity financing led by Bain Capital Life Sciences. Additional participants in the financing included existing investors Andera Partners, Gimv, Legend...
Emeryville, CA., August 12, 2019 – Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on commercializing novel vaccines, today announced Andrew A. F. Hack, M.D., Ph.D., a Managing Director at Bain Capital Life Sciences, has been appointed to Dynavax’s Board of Directors. The appointment follows an investment by Bain Capital Life Sciences in Dynavax’s...
SOUTH SAN FRANCISCO, CA, December 19, 2018 - Annexon Biosciences, a clinical stage biopharmaceutical company focused on the development of novel therapeutics through inhibition of the classical complement pathway, today announced that it has closed a $75 million Series C financing. The financing was led by new investor Bain Capital Life Sciences, with participation by Surveyor Capital (a Citadel...
SAN DIEGO, November 29, 2018 – ViaCyte, Inc., a privately-held clinical stage regenerative medicine company, today announced an $80 million Series D financing led by Bain Capital Life Sciences and joined by TPG and RA Capital Management, as well as existing investor, Sanderling Ventures, and several individual supporters of the Company. Proceeds from the financing will be used to further...
BOSTON and NEW YORK, October 23, 2018 – Bain Capital, LP and Pfizer Inc. (NYSE: PFE) today announced the creation of Cerevel Therapeutics, LLC (“Cerevel”), a new biopharmaceutical company focused on developing drug candidates to treat disorders of the central nervous system (CNS). Pfizer is contributing a portfolio of pre-commercial neuroscience assets to Cerevel, which include three...
LOWELL, MA, May 2, 2018 – Rapid Micro Biosystems, the leading provider of automated, growth-based, rapid microbial detection technology for the healthcare product manufacturing sector, announced that it has secured $60 million in equity financing led by new investors Bain Capital Life Sciences and Xeraya Capital. The new funding round also includes a commitment from another new investor, Asahi...
EVANSTON, ILLINOIS, December 18, 2017 – Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today is announcing the completion of a $70 million Series B financing to fund advancement of its expanding clinical-stage pipeline. The financing was led by Bain Capital Life Sciences. Additional new investors include Adage...
JENA, GERMANY, October 13, 2017 - InflaRx, the biopharmaceutical company developing new therapeutics in the terminal complement space, announced today a $ 55M Series D financing and investment round. The round was co-led by Bain Capital Life Sciences LP, Cormorant Asset Management LLC and RA Capital Management LLC and complemented by certain investment funds managed by a leading US investment...
NEW YORK, September 25, 2017 - SpringWorks Therapeutics, a mission-driven medicines company dedicated to developing innovative potential new treatments for underserved patient communities, announced its launch today with a completed $103 million Series A financing funded by Bain Capital Life Sciences, Bain Capital Double Impact, OrbiMed, Pfizer (NYSE:PFE) and LifeArc (formerly known as...
[email protected]'s Dinners4Dads fundraiser raised $27,000 to provide healthy meals to fathers who were too sick to m… https://t.co/SI55oDTt3K
Join @TheJimmyFund Summer Wellness Series to support @DanaFarber while getting fit with virtual classes.… https://t.co/CqVfMgdwSX
Despite cancellations for COVID-19, @Cycle4Survival raised $40 million for rare cancer research. Read the full stat… https://t.co/BladEkytYM
So far this year, @PanMass has raised over $15 million to support cancer research and life-saving work @DanaFarber.… https://t.co/RNaCWg3Ce8
Read about Bobby Richards' experience leaving a 9-5 job in finance for service with @CityYear.… https://t.co/L9iuQmV94F
Learn more about how one @CityYear team performs virtual service. https://t.co/tq6nIQBYP1 https://t.co/JpuCLRTzCV
Marisa Desjarlais shares how @YearUp has continued to provide exceptional support to its community. Read her full s… https://t.co/6RxgzM3sEt
There is still time to register as a virtual rider for #PMC2020. Learn more from @PanMass. https://t.co/W4Ibgorn2y
Gina Solomon shares her story of fighting cancer during COVID-19 and how @DanaFarber has been there to help. https://t.co/nLlQWcHy7O
Riders in #PMC2020 can integrate their @PanMass profile with Strava. Read more. https://t.co/5NrGNUgIec